Literature DB >> 10767830

The importance of skip lesions in temporal arteritis.

D N Poller1, Q van Wyk, M J Jeffrey.   

Abstract

AIM: To determine the frequency of skip lesions in an unselected series of temporal artery biopsies and compare the results with other series.
METHODS: The study was a retrospective review of 102 consecutive temporal artery biopsies taken in a five year period (1992-1997) in one large hospital.
RESULTS: 35 cases (34.3%) showed evidence of active cranial vasculitis with pathological evidence of inflammation of the intima or media, with or without giant cells. Three of these cases (8.5%) showed apparent skip lesions: normal intima, media, and adventitia in one segment while in other segments there was clear evidence of active vasculitis. Immunocytochemical stains for leucocyte common antigen (LCA) and CD15 were helpful in identifying the absence of intimal or medial inflammatory cell infiltrates within skip lesions. Skip lesions have been described in up to 28.3% of cases in some series, while others have not found evidence of skip lesions or have identified them in a much smaller percentage of cases.
CONCLUSIONS: In this series skip lesions were relatively rare, accounting for 8.5% of cases of active vasculitis. The degree of inflammation in temporal arteritis is discontinuous. Immunostaining for inflammatory cells, for example LCA and CD15, may be helpful in identifying the presence of an inflammatory cell infiltrate in skip lesion segments of the temporal artery.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10767830      PMCID: PMC1763281          DOI: 10.1136/jcp.53.2.137

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis.

Authors:  G G Hunder; D A Bloch; B A Michel; M B Stevens; W P Arend; L H Calabrese; S M Edworthy; A S Fauci; R Y Leavitt; J T Lie
Journal:  Arthritis Rheum       Date:  1990-08

2.  Diagnosing and managing polymyalgia rheumatica and temporal arteritis. Sensitivity of temporal artery biopsy varies with biopsy length and sectioning strategy.

Authors:  C Sudlow
Journal:  BMJ       Date:  1997-08-30

Review 3.  Temporal artery biopsy diagnosis of giant cell arteritis: lessons from 1109 biopsies.

Authors:  J T Lie
Journal:  Anat Pathol       Date:  1996

4.  Skip lesions in temporal arteritis.

Authors:  R G Klein; R J Campbell; G G Hunder; J A Carney
Journal:  Mayo Clin Proc       Date:  1976-08       Impact factor: 7.616

  4 in total
  13 in total

1.  Surgical performance for specialties undertaking temportal artery biopsies: who should perform them?

Authors:  Gavin D Galloway; Bernhard Klebe; Paul Riordan-Eva
Journal:  Br J Ophthalmol       Date:  2002-02       Impact factor: 4.638

2.  [Giant cell arteritis: etiological knowledge and diagnostic challenge for pathologists].

Authors:  S C Schaefer; H A Lehr
Journal:  Pathologe       Date:  2012-05       Impact factor: 1.011

3.  The role of temporal artery biopsies in giant cell arteritis.

Authors:  C G Davies; D J May
Journal:  Ann R Coll Surg Engl       Date:  2011-01       Impact factor: 1.891

Review 4.  The diagnosis and treatment of giant cell arteritis.

Authors:  Thomas Ness; Thorsten A Bley; Wolfgang A Schmidt; Peter Lamprecht
Journal:  Dtsch Arztebl Int       Date:  2013-05-24       Impact factor: 5.594

Review 5.  Varicella Zoster Virus in Giant Cell Arteritis: A Review of Current Medical Literature.

Authors:  Rochella A Ostrowski; Sheela Metgud; Rodney Tehrani; Walter M Jay
Journal:  Neuroophthalmology       Date:  2019-07-02

6.  Distinct macrophage phenotypes skewed by local granulocyte macrophage colony-stimulating factor (GM-CSF) and macrophage colony-stimulating factor (M-CSF) are associated with tissue destruction and intimal hyperplasia in giant cell arteritis.

Authors:  William F Jiemy; Yannick van Sleen; Kornelis Sm van der Geest; Hilde A Ten Berge; Wayel H Abdulahad; Maria Sandovici; Annemieke Mh Boots; Peter Heeringa; Elisabeth Brouwer
Journal:  Clin Transl Immunology       Date:  2020-08-27

7.  Giant cell arteritis: a closer look at its ophthalmological manifestations.

Authors:  Nuno G Pinto Ferreira; Luiz Menezes Falcão; Antonio T Alves; Fatima Campos
Journal:  BMJ Case Rep       Date:  2015-09-28

Review 8.  [Temporal arteritis (giant cell arteritis). Clinical picture, histology, and treatment].

Authors:  T Ness; C Auw-Hädrich; D Schmidt
Journal:  Ophthalmologe       Date:  2006-04       Impact factor: 1.059

Review 9.  Recent advances in temporal arteritis.

Authors:  Carol Redillas; Seymour Solomon
Journal:  Curr Pain Headache Rep       Date:  2003-08

10.  Description and Validation of Histological Patterns and Proposal of a Dynamic Model of Inflammatory Infiltration in Giant-cell Arteritis.

Authors:  José Hernández-Rodríguez; Giuseppe Murgia; Irama Villar; Elías Campo; Sarah L Mackie; Aruna Chakrabarty; Elizabeth M A Hensor; Ann W Morgan; Carme Font; Sergio Prieto-González; Georgina Espígol-Frigolé; Josep M Grau; Maria C Cid
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.